• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Clinical Trial Guidelines Updated & Various Draft Product Guidelines Issued

Clinical Trial Guidelines Updated & Various Draft Product Guidelines Issued

Monday, 28 September 2020 / Published in Medical Device, News, NMPA Registration in China

Clinical Trial Guidelines Updated & Various Draft Product Guidelines Issued

On September 2, 2020, the Beijing MPA announced the clinical trial guidelines for medical devices in the Beijing municipalities. Required action items before, during, and after the clinical trial  were addressed.

Also, the CMDE (Center of Medical Device Evaluation, NMPA) announced the draft guidelines for the technical review of 3 test reagents and 1 medical device software, the clinicl trial of 1 test reagent, and the clinical evaluation for 2 medical devices.

Technical Review Guidelines (Draft)

  • Test reagents for cryptococcus antigen
  • Test reagents for rotavirus antigen
  • Test reagents for mutation in deafness-associated genes
  • Medical device software for cyber security
  • Drug-device combined products (under development)

Clinical Trial Guidelines (Draft)

  • Test reagents for anti-tumor medication already on the market

Clinical Evaluation Guidelines (Draft)

  • Medical magnetic resonance imaging (MRI) system
  • Ultrasonic cutting and hemostasis system for soft tissue

The CMDE began soliciting public comments once the draft guidelines were announced.

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Clinical Trials, Draft Guidelines, Technical Review Guidelines

What you can read next

Cisema Expands China Footprint with New Offices in Tianjin and Jinan
contract manufacturing of Hong Kong medical device and drug in GBA
Contract manufacturing of Hong Kong medical device and drug in GBA supported by China NMPA
Dental adhesive products registration review guidelines
Dental adhesive products registration review guidelines issued by the CMDE

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Registration of Pharmaceuticals in Hong Kong
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • china power switchgear control gear assemblies standard update

    China power switchgear and control gear assemblies standard GB/T 7251 update

    China power switchgear and control gear assembl...
  • China medical device supervision inspection results

    China medical device supervision inspection results

    China medical device supervision inspection res...
  • China toothpaste filing requirements

    China Toothpaste Filing Requirements

    China Toothpaste Filing Requirements were issue...
  • Building Successful China Medtech Market Entry Strategies

    Webinar | Building Successful China Medtech Market Entry Strategies – From the Market Access Perspective

    Building successful China Medtech market entry ...
  • China cosmetic regulatory violation

    China cosmetic regulatory violation cases reported by the NMPA

    China cosmetics regulatory violation cases were...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2003-2023 Cisema. All rights reserved.

TOP